Compare · ACN vs LSAQ
ACN vs LSAQ
Side-by-side comparison of Accenture plc (ACN) and LifeSci Acquisition II Corp. (LSAQ): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACN operates in Consumer Discretionary, while LSAQ operates in Finance - the two are in different parts of the market.
- ACN carries a market cap of $167.14B.
- ACN has hit the wire 33 times in the past 4 weeks while LSAQ has been quiet.
- ACN has more recent analyst coverage (25 ratings vs 0 for LSAQ).
- Company
- Accenture plc
- LifeSci Acquisition II Corp.
- Price
- -
- -
- Market cap
- $167.14B
- -
- 1M return
- +16.29%
- -
- 1Y return
- +0.97%
- -
- Industry
- Business Services
- Business Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- 2020
- News (4w)
- 33
- 0
- Recent ratings
- 25
- 0
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
LifeSci Acquisition II Corp.
LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.
Latest ACN
- SEC Form SCHEDULE 13G filed by Accenture plc
- Strategy/Reinvention Svcs Ofcr Sharma Manish was granted 68 units of Class A ordinary shares, increasing direct ownership by 0.64% to 10,626 units (SEC Form 4)
- Chief Leadership & HR Officer Clifford Katherine Lee was granted 65 units of Class A ordinary shares, increasing direct ownership by 0.93% to 7,058 units (SEC Form 4)
- General Counsel, Corp Sec, CRO Unruch Joel was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.45% to 22,993 units (SEC Form 4)
- CEO-Americas Walsh John F was granted 103 units of Class A ordinary shares, increasing direct ownership by 0.33% to 31,523 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 144 units of Class A ordinary shares, increasing direct ownership by 0.29% to 49,054 units (SEC Form 4)
- Chief Operating Officer Hogan Catherine Kiernan was granted 80 units of Class A ordinary shares, increasing direct ownership by 0.62% to 13,084 units (SEC Form 4)
- Chief Financial Officer Park Angie Y was granted 102 units of Class A ordinary shares, increasing direct ownership by 0.72% to 14,327 units (SEC Form 4)
- Chief Accounting Officer Burgum Melissa A was granted 75 units of Class A ordinary shares, increasing direct ownership by 0.77% to 9,836 units (SEC Form 4)
- Ontario's Workplace Safety and Insurance Board Cuts Employer Registration Time from Days to Minutes with Guidewire
Latest LSAQ
- SEC Form 3 filed by new insider De Silva Bhooshitha B.
- SEC Form 3: New insider Pharmaceutical Product Development, Llc claimed ownership of 17,314,315 shares
- SEC Form 3: New insider Lux Capital Management, Llc claimed ownership of 15,164,556 shares
- SEC Form SC 13D filed by LifeSci Acquisition II Corp.
- SEC Form SC 13D filed by LifeSci Acquisition II Corp.
- SEC Form 4: Redmile Group, Llc was granted 14,808,234 shares (Amendment)
- SEC Form SC 13D filed by LifeSci Acquisition II Corp.
- SEC Form 4 filed by Tiwari Neil
- SEC Form 3 filed by new insider Tiwari Neil
- SEC Form SC 13G filed by LifeSci Acquisition II Corp.